UNITED THERAPEUTICS CORP sold 19.6% of their position (500K shares) of TRANSMEDICS GROUP, INC. on the open market
Open‑market sale worth $9.38M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/10/2019ACC: 0001104659-19-071451
10% Owner
Since May 2019
-500K
Net shares
Net seller
$9.38M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
500K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−500K
Price / share
$18.75
Trade value
$9.38M
% of position
19.6%
12/9/2019
2.55M→2.05M
Total
Net shares
−500K
Net value
-$9.38M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/9/2019 | S · Sale | −500K | $18.75 | $9.38M | 19.6% | 2.55M | 2.05M |
| Total | −500K | -$9.38M | ||||||
Derivative Transactions0
No derivative transactions reported